Dangerous liaisons in prostate cancer. Clinical and biological implications of recurrent gene fusions;"Dangerous liaisons" im Prostatakarzinom: Klinische und biologische Bedeutung rekurrenter Genfusionen

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 121-125

  Perner, S ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

ERG rearrangement; ETS genes; Gene fusion; In situ hybridization fluorescence; Prostate cancer

Indexed keywords

ERG PROTEIN, HUMAN; SERINE PROTEINASE; TMPRSS2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR ETS;

CELL TRANSFORMATION; EXON; GENE EXPRESSION REGULATION; GENE FUSION; GENE REARRANGEMENT; GENETICS; GENOTYPE; HUMAN; MALE; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENOTYPE; HUMANS; MALE; ONCOGENE FUSION; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ETS; SERINE ENDOPEPTIDASES; TRANS-ACTIVATORS;

EID: 79953226340     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1345-7     Document Type: Article

References (22)

1. Mitelman F (2000) Recurrent chromosome aberrations in cancer. Mutat Res 462(2-3):247-253
2. Mitelman F, Johansson B, Mertens F (2004) Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36(4):331-334
3. Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7(4):233-245
4. Tomlins SA, Rhodes DR, Perner S et al (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310(5748):644-648
5. Tomlins SA, Bjartell A, Chinnaiyan AM et al (2009) ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol 56(2):275-286
6. Perner S, Demichelis F, Beroukhim R et al (2006) TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66(17):8337-8341
7. Braun M, Scheble VJ, Scharf G et al (o J) Relevance of cohort design for studying the prevalence of the ERG rearrangement in prostate cancer. (manuscript in review)
8. Perner S, Mosquera JM, Demichelis F et al (2007) TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 31(6):882-888
9. Mosquera JM, Perner S, Genega EM et al (2008) Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 14(11):3380-3385
10. Cerveira N, Ribeiro FR, Peixoto A et al (2006) TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8(10):826-832
11. Barry M, Perner S, Demichelis F et al (2007) TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Urology 70(4):630-633
12. Perner S, Svensson MA, Hossain RR et al (2009) ERG rearrangement metastasis patterns in locally advanced prostate cancer. Urology 75(4)762-767
13. Scheble VJ, Braun M, Wilbertz T et al (2010) ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. Mod Pathol
14. Scheble VJ, Braun M, Wilbertz T et al (2010) ERG rearrangement in small cell prostatic and lung cancer. Histopathology 56(7):937-943
15. Demichelis F, Fall K, Perner S et al (2007) TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 26(31):4596-4599
16. Attard G, Clark J, Ambroisine L et al (2008) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27(3):253-263
17. Setlur SR, Mertz KD, Hoshida Y et al (2008) Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 100(11):815-825
18. Bonkhoff H, Fixemer T, Hunsicker I et al (2001) Progesterone receptor expression in human prostate cancer: correlation with tumor progression. Prostate 48(4):285-291
19. Cheng J, Lee EJ, Madison LD et al (2004) Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566(1-3):169-172
20. Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561-566
21. Rikova K, Guo A, Zeng Q et al (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131(6):1190-1203
22. Perner S, Wagner PL, Demichelis F et al (2008) EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 10(3):298-302